Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen
Tianying Zhang, Quan Yuan, Jinghua Zhao, et al.
Gut (2015) Vol. 65, Iss. 4, pp. 658-671
Closed Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Therapeutic strategies for hepatitis B virus infection: towards a cure
Gregory Fanning, Fabien Zoulim, Jinlin Hou, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 827-844
Closed Access | Times Cited: 465
Adaptive immunity in HBV infection
Antonio Bertoletti, Carlo Ferrari
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S71-S83
Closed Access | Times Cited: 405
Immunobiology and pathogenesis of hepatitis B virus infection
Matteo Iannacone, Luca G. Guidotti
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 19-32
Closed Access | Times Cited: 338
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R. Burton, Laura J. Pallett, Laura E. McCoy, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4588-4603
Open Access | Times Cited: 259
PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
Loghman Salimzadeh, Nina Le Bert, Charles‐Antoine Dutertre, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4573-4587
Open Access | Times Cited: 222
Antibody therapies for the prevention and treatment of viral infections
Georgina To’a Salazar, Ningyan Zhang, Tong‐Ming Fu, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 168
Experimental in vitro and in vivo models for the study of human hepatitis B virus infection
Lena Allweiss, Maura Dandri
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S17-S31
Closed Access | Times Cited: 117
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
Mala K. Maini, Alice R. Burton
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 662-675
Open Access | Times Cited: 110
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Dan Li, Wenhui He, Ximing Liu, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 101
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
Zhongji Meng, Yuanyuan Chen, Mengji Lu
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 91
Immunotherapy for Chronic Hepatitis B Virus Infection
Antonio Bertoletti, Nina Le Bert
Gut and Liver (2018) Vol. 12, Iss. 5, pp. 497-507
Open Access | Times Cited: 91
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Huajun Zhao, Xianyu Shao, Yating Yu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Xiaowen Wang, Qingyang Dong, Qian Li, et al.
Gastroenterology (2018) Vol. 154, Iss. 8, pp. 2222-2236
Closed Access | Times Cited: 77
Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang, Fusheng Wang, Zheng Zhang
Frontiers of Medicine (2017) Vol. 11, Iss. 4, pp. 490-501
Closed Access | Times Cited: 65
A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway
Junfang Zhang, Hualong Xiong, Jiali Cao, et al.
Theranostics (2017) Vol. 8, Iss. 2, pp. 549-562
Open Access | Times Cited: 64
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations
Qiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 335-349.e6
Open Access | Times Cited: 61
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 1, pp. 17-30
Open Access | Times Cited: 49
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1138
Open Access | Times Cited: 21
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis
Riccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7651-7651
Open Access | Times Cited: 17
Bioinspired Artificial Nanodecoys for Hepatitis B Virus
Xuan Liu, Lunzhi Yuan, Liang Zhang, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 38, pp. 12499-12503
Open Access | Times Cited: 55
HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
Lunzhi Yuan, Jing Jiang, Xuan Liu, et al.
Gut (2019) Vol. 68, Iss. 11, pp. 2044-2056
Open Access | Times Cited: 47
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers
Verena Hehle, Maxime Beretta, Maryline Bourgine, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 10
Open Access | Times Cited: 46
Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response
Zhiyong Ma, Ejuan Zhang, Gao Shicheng, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 43
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection
Valeria Fumagalli, Pietro Di Lucia, Valentina Venzin, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 39
<p>cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication</p>
Maura Dandri, Joerg Petersen
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3873-3886
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top